Catalyst Biosciences Inc logo

Catalyst Biosciences Inc

0
FRA:HGF2 (USA)  
€ 7.40 (+1377.84%) Oct 30
At Loss
Market Cap:
€ 18.39M ($ 19.90M)
Enterprise V:
€ -2.09M ($ -2.26M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
6-1 Month Momentum % 146.23
12-1 Month Momentum % -21.2

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -1665.73

GF Value Rank

Name Current Vs Industry Vs History